Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey

Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey

Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB97-AB97
Hauptverfasser: Trudo, Frank J., MD, MBA, Davis, Jill R., MS, Small, Mark, Siddall, James, Pike, James
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.317